Nascent Biotech NBIO Stock
Nascent Biotech Price Chart
Nascent Biotech NBIO Financial and Trading Overview
| Nascent Biotech stock price | 0.0004 USD |
| Previous Close | 0.0003 USD |
| Open | 0.0005 USD |
| Bid | 0.04 USD x 0 |
| Ask | 0.05 USD x 0 |
| Day's Range | 0.0005 - 0.0005 USD |
| 52 Week Range | 0.0001 - 0.13 USD |
| Volume | 15K USD |
| Avg. Volume | 6.9K USD |
| Market Cap | 51.67K USD |
| Beta (5Y Monthly) | 1.822 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NBIO Valuation Measures
| Enterprise Value | 63.27K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Nascent Biotech Stock Price History
| Beta (5Y Monthly) | 1.822 |
| 52-Week Change | 50.00% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.13 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.000736 USD |
| 200-Day Moving Average | 0.002825 USD |
NBIO Share Statistics
| Avg. Volume (3 month) | 6.9K USD |
| Avg. Daily Volume (10-Days) | 400 USD |
| Shares Outstanding | 172.22M |
| Float | 135.39M |
| Short Ratio | N/A |
| % Held by Insiders | 21.51% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2024 |
| Most Recent Quarter (mrq) | June 30, 2024 |
| Next Fiscal Year End | March 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -854.34% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -297626 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1924848 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 47.39K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 59K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.306 |
| Book Value Per Share (mrq) | -0.003 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1348089 USD |
| Levered Free Cash Flow (ttm) | -825141 USD |
Profile of Nascent Biotech
| Country | United States |
| State | FL |
| City | North Palm Beach |
| Address | 631 US Hwy 1 |
| ZIP | 33408 |
| Phone | 612 961 5656 |
| Website | https://www.nascentbiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.
Q&A For Nascent Biotech Stock
What is a current NBIO stock price?
Nascent Biotech NBIO stock price today per share is 0.0004 USD.
How to purchase Nascent Biotech stock?
You can buy NBIO shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nascent Biotech?
The stock symbol or ticker of Nascent Biotech is NBIO.
Which industry does the Nascent Biotech company belong to?
The Nascent Biotech industry is Biotechnology.
How many shares does Nascent Biotech have in circulation?
The max supply of Nascent Biotech shares is 172.22M.
What is Nascent Biotech Price to Earnings Ratio (PE Ratio)?
Nascent Biotech PE Ratio is now.
What was Nascent Biotech earnings per share over the trailing 12 months (TTM)?
Nascent Biotech EPS is 0 USD over the trailing 12 months.
Which sector does the Nascent Biotech company belong to?
The Nascent Biotech sector is Healthcare.